Apeiron bags €25m from EIB Supported by the European Fund for Strategic Investments (EFSI), the European Investment Bank (EIB) has granted a €25m loan to the Austrian pediatric cancer specialist Apeiron Biologics AG to … more ➔
Implementation of EU Unitary Patent Court... In mid-June, the German Federal Constitutional Court asked the German President not to sign legislation designed to implement the EU Unified Patent Court (UPC, EU Agreement 16351/12) and Unitary … more ➔
Daratumumab meets endpoint as first-line m...Danish Genmab A/S anti-CD38 antibody daratumumab has met the endpoint of progression-free survival in an interim analysis of Genmabs pivotal Phase III study aimed at receiving FDA approval as first-line … more ➔
Macrophage Pharma backed by Merck VenturesMerck Ventures has joined the Series A investor syndicate of the British immuno-oncology specialist Macrophage Pharma Ltd. more ➔
Parkinson’s: factor protects from ne... Scientists at Swedish Karolinska Institute have identified a factor that supports growth of midbrain dopaminergic (mDA) neurons, the nerve cells that degenerate during of Parkinsons disease. more ➔
Topas Therapeutics lands option deal with...Evotec’s immunology spin-out Topas Therapeutics has inked a multi-year R&D collaboration with pharma major Eli Lilly. The initial focus of research, which will be financed by Eli Lilly, is on identification … more ➔
Medivir licenses HCV drug MIV-802 to Chine...Medivir AB has exclusively licenced Greater China development and commercialisation rights of its preclinical candidate drug MIV-802 to Chinese drug developer Ascletis Bioscience Co. Ltd. more ➔
Swedish reasearchers link up cancer surviv...Using a national supercomputer, Swedish researchers have analysed how protein expression of the 315 known cancer genes translates into cancer overall survival. more ➔
Metsä Group started up its bioproduct mil...Finnish Metsä Group has started its mill for bio-based products. The €1.2bn investments production capacity is 1.3 million tonnes of softwood pulp a year. more ➔
Oxford Immunotec value drops after public...UK-headquartered immunodiagnostics specialist Oxford Immunotec Global plc’s share value slipped by $1.31 to $16.02 after the company raised US-$40.125m on Monday in an public offering of 2.5 million … more ➔
